XENON PHARMACEUTICALS INC. Key Metrics

2 years of history · ending 2025-12-31 · SEC EDGAR

Forensics

Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.

F-Score (Piotroski 0-9)

Z-Score (Altman; <1.81 = distress)

Per Share Metrics

Expense Ratios

Working Capital Analysis

Valuation Multiples

Enterprise Value Multiples

52-Week Range

Trailing Returns

ROIC vs WACC

Yields

Capital Deployment Yields

EPS (Diluted)
$-4
Book Value Per Share
$7
Free Cash Flow Per Share
$-4
Cash Per Share
$3
Revenue Per Share
$0
OCF Per Share
$-4
Return on Equity
-51.8%
Return on Assets
-48.3%
Return on Invested Capital
-44.1%
Debt to Equity
Current Ratio
13.42
Quick Ratio
13.42
Asset Turnover
0.01
Days Sales Outstanding
R&D / Revenue
4012.5%
SBC / Revenue
716.1%
Capex / Revenue
10.7%
Working Capital
$519M
Net Current Asset Value
$509M
Invested Capital
$582M
OCF / Net Income
0.81
FCF / Net Income
0.81
Accruals Ratio (Sloan)
-10.5%
Net Debt
$-549M
Net Debt / EBITDA
1.48
Interest Coverage
Cash Coverage
Capex Coverage
-349.33
Tangible Common Equity
$582M
TCE / Total Assets
91.9%
NOPAT
$-295M
Cash ROIC
-41.9%
WC / Revenue
6918.1%
Capex / D&A
0.31
Reinvestment Rate
0.5%
Asset Growth vs Revenue Growth
Revenue 5Y CAGR
-25.3%
Book Value 5Y CAGR
27.7%
Stock Price (FY-end)
$45
Market Cap
$3.55B
P/E Ratio
P/S Ratio
473.62
P/B Ratio
6.11
P/TB Ratio
6.11
P/OCF Ratio
Enterprise Value
$3.00B
EV / EBITDA
EV / Sales
400.44
FCF Yield
-7.9%
Shareholder Yield
-1.5%
R&D Yield
8.5%
Capex Yield
0.0%
Operating Leverage
Graham Number
Shares Variation (YoY)
1.7%
Beta (5Y)
0.86
Cost of Equity
8.8%
Cost of Debt (after tax)
WACC
ROIC - WACC Spread
52W High
$46
52W Low
$28
Trailing Return 1Y
15.4%
Trailing Return 5Y
195.1%
F-Score (Piotroski)
2.00
Z-Score (Altman)
37.76

Earnings Forecasts

Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).

Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.

EPS — Consensus vs Actual

Revenue — Consensus vs Actual

Stock Price on Earnings Dates